Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Gossamer Bio Inc fell by 79.86m. Cash Flow from Financing totalled 190.15m or -- of revenues. In addition the company used 159.16m for operations while cash used for investing totalled 110.97m.
Cash flow per share | -0.3077 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2389 |
---|---|
Tangible book value per share | 0.2389 |
More ▼
Balance sheet in USDView more
Current ratio | 6.74 |
---|---|
Quick ratio | -- |
Total debt/total equity | 3.64 |
---|---|
Total debt/total capital | 0.7847 |
More ▼